3 completed, 1 enrolling by invitation, 1 not yet recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Enrolling by invitation 1 |
Follow Immunovia, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Observational Registry Evaluating the Clinical Impact of the Blood-Based Biomarker Test for Early-Stage Pancreatic Ductal Adenocarcinoma PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage I | Not yet recruiting | Immunovia, Inc. | 400 | 2026-09-01 | 2026-09-04 | |
| Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI) PancreaSure - Cancer of the Pancreas, Pancreatic Cancer | Completed | Immunovia, Inc. | 386 | 2025-02-11 | 2025-04-27 | |
| Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer Pancreatic Cancer Stage I, Pancreatic Cancer Stage II | Completed | Immunovia, Inc. | 1066 | 2024-09-02 | 2025-04-27 | |
| The PREPAIRD Study: Personalized Surveillance for Early Detection of Pancreatic Cancer in High Risk Individuals Annual surveillance - Hereditary Pancreatic Cancer | Not applicable | Enrolling by invitation | Oslo University Hospital | 200 | 2022-09-01 | 2023-02-22 |
| A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer | Completed | Immunovia, Inc. | 1349 | 2016-01-19 | 2022-03-31 |
Pancreatic Neoplasms (4) · Pancreatic carcinoma, familial (2) · Dysplastic Nevus Syndrome (1)
United States (3) · Canada (2) · Norway (2) · Italy (1) · Spain (1) · Sweden (1) · United Kingdom (1)